Report Categories
View AllRecent Articles
View All
Indian Stock Market Faces Profit Booking as Nifty Sensex Snap Rally
EasyJet Assures Summer Flights Unaffected by Jet Fuel Shortages Amid Iran War Uncertainty
Fanatics secures FIFA exclusive license to dominate global sports collectibles market
INGs AIPowered Trading System Built in Hours Draws Wall Street Attention
Brainbees Solutions Narrows Q4 Loss as Firstcry Parent Reports 12 Revenue Growth
Historic UKGulf Trade Deal Could Add Billions to British Economy
AMZN Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment
German American Bancorp Inc Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher
GIB Q1 2026 Earnings EPS Misses Estimates Amid Disciplined Execution
Lennar LEN Q1 2026 Earnings EPS Miss Highlights Ongoing Housing Market Headwinds
ANRO Q1 2026 Earnings Significant EPS Miss Highlights EarlyStage Development Costs
Sachem Capital Corp SCCF Q4 2025 Earnings Massive EPS Beat on Minimal Expectations
Zumiez Inc ZUMZ Edges Higher as Retail Sector Finds Footing
ITHAX Acquisition Corp III ITHAU Units Hold Steady at 1004 Amid Consolidation
SSR Mining Inc SSRM Gains 343 as Gold Miner Approaches Key Resistance
Niagen Bioscience Inc NAGE Retreats 343 as Shares Approach Key Support
Titan America TTAM Holds Steady Near Support Resistance Awaits
External Links
Beyond Inc to Acquire Buy Buy Baby Brand Reuniting with Bed Bath Beyond
BHP Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower
Synopsys Hovers Near Support as SNPS Shares Consolidate
CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin Revenue Details Not Provided
Revolve Group RVLV Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
Norfolk Southern Q1 2026 Earnings EPS Beat Lifts Shares Despite Macro Headwinds
MOS Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher
Camden Property Trust CPT Q1 2026 Earnings Strong EPS Beat Signals Resilient Multifamily Operations
Insperity Q1 2026 Earnings EPS Surpasses Estimates by 511
Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain